FMII
PTGX icon

Farmers & Merchants Investments Inc’s Protagonist Therapeutics PTGX Stock Holding History

Farmers & Merchants Investments Inc’s Portfolio PTGX Stock Details PTGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.29K Hold
35
– – ﹤0.01% 1054
2026
Q1 		$3.69K Hold
35
– – ﹤0.01% 1066
2025
Q4 		$3.06K Hold
35
– – ﹤0.01% 1106
2025
Q3 		$2.33K Hold
35
– – ﹤0.01% 1207
2025
Q2 		$1.93K Hold
35
– – ﹤0.01% 1239
2025
Q1 		$1.69K Hold
35
– – ﹤0.01% 1279
2024
Q4 		$1.35K Buy
+35
New +$1.53K ﹤0.01% 1362

Other funds holding PTGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Farmers & Merchants Investments Inc's PTGX Position: Q2 2026 in Review

Farmers & Merchants Investments Inc held its Protagonist Therapeutics (PTGX) position steady in Q2 2026 at 35 shares worth $4.29K. The position accounts for ﹤0.01% of the portfolio, ranked #1054.

Farmers & Merchants Investments Inc first reported a position in PTGX in Q4 2024 and has held it in 7 quarters since. 181 funds tracked by Wall St. Rank hold PTGX as of Q2 2026.

  • Farmers & Merchants Investments Inc held 35 shares of Protagonist Therapeutics worth $4.29K as of Q2 2026.
  • Farmers & Merchants Investments Inc left its Protagonist Therapeutics share count unchanged in Q2 2026.
  • Protagonist Therapeutics made up ﹤0.01% of Farmers & Merchants Investments Inc's portfolio in Q2 2026, its #1054 holding.
  • Farmers & Merchants Investments Inc first reported a position in Protagonist Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 181 funds tracked by Wall St. Rank held Protagonist Therapeutics as of Q2 2026.

Based on Farmers & Merchants Investments Inc's 13F filing for Q2 2026, filed 20 Jul 2026.